drugset / Trial / NCT01400100

Effects of Intraarterial Octreotide on Pancreatic Texture

NCT01400100

Completed 26 enrolled St. Josef Hospital Bochum
RandomizedParallel-groupDouble-blindBasic science

Summary

The aim of the study is to test the hypothesis that intraarterial bolus application of 500 µg Octreotide in the gastroduodenal artery during the resectional phase of pancreatoduodenectomy in patients with soft pancreatic tissue hardens the texture of the pancreatic remnant. A primary end-point of the study is a change in pancreatic texture. A secondary end-point is the rate of postoperative pancreatic fistula.

Timeline

Start
2011-08
Primary completion
2012-02
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Octreotide Peptide 500 ug Other

Indications